Buy these 3 ASX shares to instantly diversify your portfolio

Diversification is one of the key parts to an investment strategy with ASX shares. Mitigating risk whilst still attaining high investment returns is one of the best things you can do for your portfolio.

Being focused too much on one sector, such as banks, can be a problem. That’s why I think the following three shares are good options for a strong portfolio:

Citadel Group Ltd (ASX: CGL)

Citadel is a technology business that provides secure management software for clients in various industries.

For example, it serves defence, security, education and the health industries. Evolution is a piece of software that has been used in health laboratories for over 30 years. Other Citadel offerings include anaesthetic billing software and oncology information management.

In FY18 Citadel grew earnings per share by 35.4% and grew the total dividend by 7.8%. This was impressive and there could be more profit to come with more contract wins and good recurring revenue from its existing contracts.

It’s currently trading at only 24x FY18’s earnings.

PM Capital Global Opportunities Fund Ltd (ASX: PGF)

I think most Aussie investors need to increase their exposure to international shares. The ASX only makes up 2% of the global share market.

One of the ways to get that diversification could be with a listed investment company (LIC) that invests in overseas shares such as PM Capital Global Opportunities.

It’s invested in shares in North America, Europe, Asia (not including Japan) and the UK. It invests all over the world. Since inception in December 2013 it has generated a return of 11.3% per annum after fees and expenses.

It has increased its dividend each year since March 2016 and currently offers a grossed-up dividend yield of 4.3%.

Challenger Ltd (ASX: CGF)

If I had to choose one financial business on the ASX to invest in it would be Challenger. It primarily sells annuities to retirees who are looking for a secure source of earnings from their capital. I think it’s more defensive than banks.

Demand for annuities is projected to grow for a long time because the number of over-65s is expected to grow by 40% over the next decade. More retirees should equal more clients.

New government rules will make annuities seem even more attractive to retirees.

Challenger is currently trading at 14x FY19’s estimated earnings.

Foolish takeaway

All three shares should be able to beat the ASX index return over the long-term due to where they’re focused. At the current prices both Challenger and Citadel look like good value growth shares. I am looking to add more Challenger shares to my portfolio at the current price.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited. The Motley Fool Australia owns shares of and has recommended Challenger Limited. The Motley Fool Australia owns shares of Citadel Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!